About Novartis
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Novartis
1
Novartis Pharmaceuticals
1
Clinical Trials at Novartis
During the past decade, Novartis conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy, Safety, and Tolerability of Once Daily Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) Using Formoterol Twice Daily as Active Control
2006-10-01
2008-07-01
Completed
1,732
Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Combination With Two Corticosteroid Regimens for the Treatment of Lupus Nephritis Flare
2007-02-01
2009-11-01
Completed
81
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Novartis
According to Clinical.Site data, the most researched conditions in "Novartis" are
"Chronic Obstructive Pulmonary Disease" (1 trials) and "Lupus Nephritis" (1 trials). Many other conditions were trialed in "Novartis" in a lesser frequency.
Clinical Trials Intervention Types at Novartis
Most popular intervention types in "Novartis" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Formoterol" (1 trials), "Indacaterol" (1 trials), "Methylprednisolone" (1 trials), "Mycophenolate sodium" (1 trials) and "Placebo to formoterol" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Novartis
The vast majority of trials in "Novartis" are
2 trials for "All" genders.
Clinical Trials Status at Novartis
Currently, there are NaN active trials in "Novartis".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Novartis,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Novartis, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".